Lavo Life Sciences

Lavo Life Sciences focused on employing artificial intelligence to simulate drug molecules, offering pharmaceutical companies a virtual environment to test and refine formulations. By leveraging computational power, Lavo aimed to provide insights that would streamline laboratory experiments, potentially leading to significant reductions in both time and costs associated with drug development. The ultimate goal was to de-risk the clinical trial process and accelerate the path to FDA approval, bringing new medications to market more efficiently. However, the company is now inactive.